Gilead Sciences shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Gilead Sciences
Tip: Access up to 7 years of quarterly data
All positions including Gilead Sciences held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gilead Sciences by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.3B | 58M | 74.94 |
| 2023-06-30 | $4.5B | 58M | 77.07 |
| 2023-03-31 | $4.8B | 58M | 82.97 |
| 2022-12-31 | $4.7B | 55M | 85.85 |
| 2022-03-31 | $3.3B | 56M | 59.45 |
| 2021-12-31 | $7.8B | 107M | 72.61 |
| 2021-09-30 | $8.0B | 115M | 69.85 |
| 2021-06-30 | $8.0B | 117M | 68.86 |
| 2021-03-31 | $7.9B | 123M | 64.63 |
| 2020-12-31 | $7.1B | 122M | 58.26 |
| 2020-09-30 | $7.4B | 117M | 63.19 |
| 2020-06-30 | $9.6B | 125M | 76.94 |
| 2020-03-31 | $7.2B | 96M | 74.76 |
| 2019-12-31 | $5.5B | 85M | 64.98 |
| 2019-09-30 | $4.9B | 77M | 63.38 |
| 2019-06-30 | $5.5B | 82M | 67.56 |
| 2019-03-31 | $5.1B | 78M | 65.01 |
| 2018-12-31 | $4.5B | 73M | 62.55 |
| 2018-09-30 | $5.4B | 70M | 77.21 |
| 2018-06-30 | $4.0B | 57M | 70.84 |
| 2018-03-31 | $3.2B | 43M | 75.39 |
| 2017-12-31 | $2.3B | 32M | 71.64 |
| 2017-03-31 | $1.5B | 22M | 67.92 |
| 2016-12-31 | $1.8B | 25M | 71.61 |
| 2016-09-30 | $2.2B | 28M | 79.12 |
| 2016-06-30 | $2.1B | 25M | 83.42 |
| 2016-03-31 | $2.9B | 31M | 91.86 |
| 2015-12-31 | $5.4B | 53M | 101.19 |
| 2015-09-30 | $6.9B | 70M | 98.19 |
| 2015-03-31 | $9.9B | 101M | 98.13 |
| 2014-12-31 | $10B | 97M | 104.83 |
| 2014-06-30 | $11B | 138M | 82.91 |
| 2013-12-31 | $10B | 136M | 75.15 |
| 2013-09-30 | $9.7B | 154M | 62.84 |
| 2013-06-30 | $8.0B | 157M | 51.21 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors